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HTLV-1 Tax oncoprotein is considered a key factor in
HTLV-1 pathogenicity. BRCA1 gene dysfunction can
lead to breast cancer development. In contrast to the
tumor suppressor nature of BRCA1, Tax is a potent
oncoprotein, most of its activities are strictly opposing
those of BRCA1. Therefore, we hypothesize that HTLV-
1 Tax expression in breast epithelial cells can antagonize
BRCA1 expression and functionality, thereby sensitizing
these cells to malignant transformation by environmen-
tal carcinogens. Our objective was to provide molecular
and cellular indications to validate this hypothesis.
Based on earlier findings that the milk of HTLV-1
infected women is rich in HTLV-1 infected lymphocytes
that can transfer the virus into breast epithelial cells, the
outcomes of this project may point that HTLV-1 can be
a risk factor for the development of breast cancer, with
a substantially higher risk to women who practice long-
term breastfeeding. Our results showed that Tax strongly
inhibited estrogen induced activation of BRCA-1 expres-
sion in breast cells by sequestering CBP/p300 co-activators.
Trying to explore the CBP/p300 associated mechanism of
Tax effect on BRCA1 expression, our results suggest that
Tax does not prevent the binding of CBP/p300 to ERa but
rather physically associates with the ERa-CBP/p300 to
form a tertiary reporter. Since CBP/p300 complex has sev-
eral binding domains, we believe that Tax associates with
ERa-CBP/p300 complex through binding to CBP/p300
rather than to the ERa protein. We have also found that
Tax inhibits BRCA1-mediated activation of p53-target pro-
moters. These results support the possibility of HTLV-1
involvement in breast cancer development.
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